K. Arai et al., NO APPARENT MINERALOCORTICOID RECEPTOR DEFECT IN A SERIES OF SPORADICCASES OF PSEUDOHYPOALDOSTERONISM, The Journal of clinical endocrinology and metabolism, 80(3), 1995, pp. 814-817
Pseudohypoaldosteronism (PHA) is characterized by congenital resistanc
e of the kidney and/or other mineralocorticoid target tissues to aldos
terone, resulting in excessive salt wasting. Although the mineralocort
icoid receptor (MR) was suggested as a potential locus of the defect i
n this disease, no such abnormality was found in 3 recently reported c
ases, one of whom belongs to this series of 5 patients. Molecular stud
ies of the MR complementary DNA and gene in this series of sporadic ca
ses of pseudohypoaldosteronism are reported. Four of these patients ha
d multiple mineralocorticoid target tissue resistance, whereas 1 had t
ransient isolated resistance in the kidney. A nonconservative homozygo
us mutation (C-944-->T-944, Ala(241)-->Val(241)) was identified in the
complementary DNA of 4 of the patients but was also found in 62 of 10
0 normal alleles. One of these 4 patients had an additional conservati
ve heterozygous mutation (A(760)-->G(760), Ileu(180)-->Val(180), which
was also present in 11 of 100 normal alleles. None of the patients ha
d any abnormalities in the first untranslated exon and 0.9 kilobases o
f the 5'-regulatory region of the MR gene, which were fully sequenced
and compared with the normal sequence. It is concluded that the mutati
ons identified in 4 of these 5 patients with PHA are polymorphisms, wh
ich on their own have no apparent pathophysiological significance. It
is hypothesized that the defect causing PHA might be in a post-MR step
of aldosterone action or in an unsuspected nonclassic receptor for th
is hormone.